Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
A funny thing happened to me on my way to the office a few months back. After many years in the thought and planning process our anatomic pathology laboratory with one of our hospital partners is being renovated. As part of the renovation, temporary workspaces and relocation of equipment and personnel is needed. [more] More CAP TODAY Recommends
Cortex and Zirmed offer a free webinar entitled “Five ways to get paid faster.” In this webinar, Julie Millican, billing supervisor at Trumbull Laboratories, will discuss how she reduced accounts receivable by 55 percent, achieved a 98 percent claims first-pass yield rate, submits claims faster within online claims editing tools, and more. The webinar is offered twice, once on Tuesday, March 12, and again on Thursday, March 14. [more] More CAP TODAY Recommends
Sequenom offers free webinars on its iPlex Pro Sample ID Panel and its Assay Design Suite 1.0 software. The iPlex webinar is on Wednesday, Feb. 27, while the Assay Design Suite webinar is on Thursday, March 7. Register here. More CAP TODAY Recommends
Agilent Genomics offers a free eSeminar on comprehensive next-generation sequencing solutions. The eSeminar is on Thursday, March 28 at 11 a.m. EST. The eSeminar will feature Agilent Next Generation Sequencing Solutions for Gene Regulation, a presentation by Yong Yi, the company’s associate NGS marketing director, and Simplify the Sequencing of Clinical Research Samples, a presentation by Olle Ericsson, the company’s NGS marketing director. Register for the seminar here. More CAP TODAY Recommends
